Clinical Trial Diversity Action Plans Need Timely US FDA Feedback, Groups Say

 
• By Sue Sutter
  
Diversity paper cutouts
Sponsors' clinical trial diversity action plans would benefit from FDA feedback, industry groups said. • Source: Shutterstock

More from Clinical Trials

More from R&D